- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Metastatic Merkel cell carcinoma response to nivolumab ; volume:4 ; number:1 ; day:15 ; month:11 ; year:2016 ; pages:1-4 ; date:12.2016
Journal for ImmunoTherapy of Cancer ; 4, Heft 1 (15.11.2016), 1-4, 12.2016
- Urheber
-
Walocko, Frances M.
- Beteiligte Personen und Organisationen
-
Scheier, Benjamin Y.
Harms, Paul W.
Fecher, Leslie A.
Lao, Christopher D.
SpringerLink (Online service)
- DOI
-
10.1186/s40425-016-0186-1
- URN
-
urn:nbn:de:1111-201612048360
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Walocko, Frances M.
- Scheier, Benjamin Y.
- Harms, Paul W.
- Fecher, Leslie A.
- Lao, Christopher D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
Successful Treatment with Nivolumab in a Patient with Metastatic Salivary Duct Carcinoma
Metastatic Merkel Cell Carcinoma of the Abdominal Wall
Challenges of New Approaches in Metastatic Merkel Cell Carcinoma
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
Successful Treatment with Nivolumab in a Patient with Metastatic Salivary Duct Carcinoma
Metastatic Merkel Cell Carcinoma of the Abdominal Wall
Challenges of New Approaches in Metastatic Merkel Cell Carcinoma
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
Erratum to: Metastatic Merkel cell carcinoma response to nivolumab
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
Immune-Related Meningoencephalitis following Nivolumab in Metastatic Renal Cell Carcinoma
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
Successful Treatment with Nivolumab in a Patient with Metastatic Salivary Duct Carcinoma
Metastatic Merkel Cell Carcinoma of the Abdominal Wall
Challenges of New Approaches in Metastatic Merkel Cell Carcinoma